2008
DOI: 10.1590/s1516-93322008000100020
|View full text |Cite
|
Sign up to set email alerts
|

Origens e trajetórias da indústria farmacêutica no Brasil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…These last two achievements contributed to the growth of Brazilian pharmaceutical companies, which enlarged their production capacity and enhanced their technological capabilities. However, firms that failed to meet the new requirements eventually had to shut down their operations (Caliari and Ruiz, 2014; Gadelha and Costa, 2012; Hasenclever et al , 2018; Paranhos et al , 2020b; Strucker and Cytrynowicz, 2007; Tigre et al , 2016). Two more legal changes impact on Brazilian pharmaceutical sector.…”
Section: Theoretical Backgroundmentioning
confidence: 99%
“…These last two achievements contributed to the growth of Brazilian pharmaceutical companies, which enlarged their production capacity and enhanced their technological capabilities. However, firms that failed to meet the new requirements eventually had to shut down their operations (Caliari and Ruiz, 2014; Gadelha and Costa, 2012; Hasenclever et al , 2018; Paranhos et al , 2020b; Strucker and Cytrynowicz, 2007; Tigre et al , 2016). Two more legal changes impact on Brazilian pharmaceutical sector.…”
Section: Theoretical Backgroundmentioning
confidence: 99%